Breakfast Symposium AGW 2026
RSVP to Breakfast Symposium at AGW 2026
Treating to Target in Ulcerative Colitis:
From Principle to Practice
Saturday 29 August, 2026
7:00–8:20 am (AWST)
Perth Convention and Exhibition Centre, Meeting Room 8
Join your colleagues for an expert-led breakfast symposium.
As treatment goals evolve beyond symptom control towards disease clearance, this session will examine the clinical consequences of persistent inflammation and the rationale for earlier use of advanced therapy.
Presentations will draw on real-world cases and Australian experience to provide practical guidance on when to escalate treatment.
Associate Professor
Jake Begun
Director of Gastroenterology, Lead of IBD research,
Mater Hospital, Brisbane, QLD
Associate Professor
Britt Christensen
Head of IBD Unit, The Royal Melbourne Hospital, Clinical Associate Professor, University of Melbourne, VIC
Agenda
| 7.00am | Breakfast available |
| 7.20am | Welcome and introduction – Chair A/Prof Jake Begun |
| 7.25am | Start with the end in mind: The case for early advanced therapy and treatment selection with intent A/Prof Jake Begun |
| 7.45am | From symptom control to disease clearance: Setting and hitting deeper targets in Australian practice A/Prof Britt Christensen |
| 8.05am | Panel discussion Treating to target in ulcerative colitis: Putting it into practice A/Prof Britt Christensen and A/Prof Jake Begun |
| 8.20am | Close |